Sean , you are right , Alz is a terrible disease , but with

New Post Public Reply Private Reply Replies (0) Message Board
misiu143 sean007 #93888
680
Sean , you are right , Alz is a terrible disease , but with COVID some dying within a week or two,

They don't even have a chance to develop Alz , so why FDA show no mercy to our critical patients with NO OTHER treatment available ..
with a very good results we had even with 2 treatments..

All IMO.




1

CytoDyn Inc (CYDY) Stock Research Links

CYDY Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Exploring Avast's Comprehensive Digital Privacy Solutions

Updated Category News Views 208

Understanding Digital Privacy in Today's World As our lives become increasingly digital, online privacy concerns have surged, especially when it comes to browsing and online shopping. In this evolving landscape, consumers may be unsure about how to protect their sensitive data from various risks, such as theft, tracking, and manipulation. One company at the forefront of...

Continue Reading
Nxera Pharma and Eli Lilly Partner to Tackle Metabolic Conditions

Updated Category News Views 334

Nxera Pharma and Eli Lilly Partner to Tackle Metabolic Conditions Nxera Pharma Co., Ltd. has marked an important milestone thanks to its collaboration with Eli Lilly and Company, focusing on innovative solutions for diabetes and metabolic diseases. Through this partnership, Nxera realizes a significant step forward, receiving a payment tied to this milestone achievement....

Continue Reading
Esperion Grants Restricted Stock Units to New Employees

Updated Category News Views 111

Esperion's Recent Announcement on Restricted Stock Units ANN ARBOR, Mich. -- Esperion (NASDAQ: ESPR) has made an exciting move by granting 77,650 restricted stock units (RSUs) to 23 new employees as part of its ongoing commitment to attract talented individuals. This announcement was made on a notable day for the company. The Inducement Equity Incentive Plan Explained The...

Continue Reading
Arch Capital Group Celebrates Legacy of Dinos Iordanou

Updated Category News Views 81

Remembering Dinos Iordanou: A Legacy Honored Arch Capital Group Ltd. recently held a heartfelt memorial event to commemorate the life and legacy of its former CEO, Dinos Iordanou. This gathering brought together family, friends, and colleagues, giving everyone a chance to honor the remarkable contributions Iordanou made to the company and the insurance industry. A...

Continue Reading